| mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.01 |
| mRNA |
RO-3306 |
GDSC1000 |
pan-cancer |
AAC |
0.097 |
0.01 |
| mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.01 |
| mRNA |
CHEMBL374350 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.01 |
| mRNA |
prochlorperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.01 |
| mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.01 |
| mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.01 |
| mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.01 |
| mRNA |
BRD-A71883111 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.01 |
| mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
-0.12 |
0.01 |